Comparing two misoprostol doses to start labor in women with severe obesity
Compares two misoprostol doses to start labor in adult women with severe obesity.
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Registry title
- Induction of Labor in Morbidly Obese Patients
- Status
- Recruiting
- Phase
- Early phase 1
- People taking part
- 162 people, planned
- Started
- 15 Jul 2024
- Expected to end
- May 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Misoprostol
- Record updated
- 29 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women with a BMI of 40 or more who are coming in for induction of labor. It compares two doses of misoprostol.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Morbid obesity (BMI 40 kg/m2 or more) at admission; single baby head-down, 34 weeks 0 days to 42 weeks 6 days of pregnancy; cervix opened less than 5 cm (2 in); fewer than 5 contractions per 10 minutes
- Earlier treatment
- No earlier cesarean delivery
Main reasons for not taking part
- Earlier cesarean delivery
- Reason that prevents prostaglandin treatment
- Reason that prevents vaginal birth, such as placenta previa, vasa previa or HIV with high viral load
- Major fetal anomaly or fetal demise
- Cannot give consent
This trial only enrols pregnant participants. The registry sentence this rests on: Gestational age between 34 weeks and 0 days and 42 weeks and 6 days
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Morbidly obese (BMI ≥ 40 kg/m2) at admission for induction of labor
- Speaks English or Spanish
- Gestational age between 34 weeks and 0 days and 42 weeks and 6 days
- Age 18 years old or older
- Viable, single, cephalic fetus
- Intent to proceed with cervical ripening - cervical exam: dilation < 5 cm
- Contractions < 5 per 10 minutes
Who cannot take part
- Contraindication to prostaglandin administration (significant myomectomy, prior cesarean delivery)
- History of cesarean delivery
- Contraindication to vaginal delivery (placenta previa, vasa previa, HIV with high viral load)
- Contraindications to labor (cardiac, neurosurgical, need for cesarean)
- Significant vaginal bleeding with concern for placental abruption
- Non-reassuring fetal status or fetal heart rate decelerations
- Age < 18yo
- Fetal growth restriction with abnormal umbilical artery Doppler indices
- Cervical dilation >5 cm
- Contractions >5 per 10 minutes
- Fetal demise or major fetal anomaly
- Inability to give consent
Where in United States
- University of Maryland Medical CenterBaltimore, United StatesContact: Rosa Drummond, MDTaking people
About the trial
What the trial wants to find out
The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI >40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.
The 2 groups in the trial
- Control - 25 mcg vaginal misoprostolExisting treatment, for comparison
Participants will receive 25 mcg vaginal misoprostol every 4 hours.
Treatment: Misoprostol
- Intervention - 50 mcg vaginal misoprostolTreatment being tested
Participants will receive 50 mcg vaginal misoprostol every 4 hours.
Treatment: Misoprostol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Induction of Labor in Morbidly Obese Patients: Comparison of 50 mcg and 25 mcg Misoprostol - A Randomized Control Trial
- Plain-language title
- Comparing two misoprostol doses to start labor in women with severe obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 29 July 2026